Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China

Li, SN; Li, JH; Peng, LB; Li, YM; Wan, XM

Li, YM (corresponding author), Cent South Univ, Xiangya Hosp 2, Clin Nursing Teaching & Res Sect, Changsha 410011, Peoples R China.; Li, YM (corresponding author), Cent South Univ, Xiangya Nursing Sch, Changsha 410013, Peoples R China.; Wan, XM (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha 410011, Peoples R China.

RHEUMATOLOGY AND THERAPY, 2021; 8 (2): 863

Abstract

Introduction: A phase 3 (RA-BEAM study) clinical trial reported that baricitinib (BCT) + methotrexate (MTX) had clinical improvement compared with ada......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索